학술논문
1387P Final analysis of the phase Ib/II study of sabizabulin in men with metastatic castration-resistant prostate cancer who progressed on an androgen receptor targeting agent
Document Type
Abstract
Author
Source
In Annals of Oncology September 2022 33 Supplement 7:S1177-S1177
Subject
Language
ISSN
0923-7534